[1] |
Tabatabaie O, Kasumova GG, Eskander MF,et al. Totally implantable venous access devices: a review of complications and management strategies[J]. Am J Clin Oncol, 2017, 40(1):94-105.
|
[2] |
Almasi-Sperling V, Hieber S, Lermann J, et al. Femoral placement of totally Implantable venous access ports in patients with bilateral breast cancer[J]. Geburtshilfe Frauenheilkd,2016,76(1):53-58.
|
[3] |
Wildgruber M, Borgmeyer S, Haller B,et al. Short-term and long-term outcome of radiological-guided insertion of central venous access port devices implanted at the forearm: a retrospective monocenter analysis in 1704 patients[J]. Eur Radiol, 2015,25(3):606-616.
|
[4] |
徐海萍,周琴,韩伟,等.手臂输液港与胸壁输液港常见并发症发生率比较的Meta分析[J]. 中华护理杂志,2018,53(3):352-358.
|
[5] |
仇晓霞,金光鑫,郭艳,等.肿瘤患者上臂植入输液港并发上肢静脉血栓发生率及危险因素[J]. 介入放射学杂志,2019,28(3):242-246.
|
[6] |
Bates SM, Jaeschke R, Stevens SM, et al. Diagnosis of DVT: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines [J]. Chest, 2012,141(2 Suppl):e351S-e418S.
|
[7] |
Noble S, Pasi J. Epidemiology and pathophysiology of cancer-associated thrombosis[J]. Br J Cancer, 2010, 102 Suppl 1:S2-9.
|
[8] |
Teichgräber U, Nagel SN, Kausche S. Evaluation of correlations between underlying disease and port complications[J]. Rofo, 2014,186(5):496-500.
|
[9] |
Sharp R, Cummings M, Fielder A,et al. The catheter to vein ratio and rates of symptomatic venous thromboembolism in patients with a peripherally inserted central catheter (PICC): A prospective cohort study[J]. Int J Nurs Stud, 2015,52(3):677-685.
|
[10] |
Qiu XX, Guo Y, Fan HB, et al. Incidence, risk factors and clinical outcomes of peripherally inserted central catheter spontaneous dislodgment in oncology patients: A prospective cohort study[J]. Int J Nurs Stud, 2014,51(7):955-963.
|
[11] |
Cameron AC, Touyz RM, Lang NN. Vascular complications of cancer chemotherapy [J]. Can J Cardiol, 2016, 32(7):852-862.
|
[12] |
Soultati A, Mountzios G, Avgerinou C, et al. Endothelial vascular toxicity from chemotherapeutic agents: Preclinical evidence and clinical implications[J]. Cancer Treat Rev, 2012, 38(5):473-483.
|
[13] |
石果,罗凤,张玲. 172例乳腺癌输液港静脉血栓相关因素分析[J]. 重庆医科大学学报,2016, 41(5):530-532.
|
[14] |
Goltz JP, Schmid JS, Ritter CO, et al. Identification of risk factors for catheter-related thrombosis in patients with totally implantable venous access ports in the forearm[J]. J Vasc Access, 2012, 13(1):79-85.
|
[15] |
浙江省植入式静脉输液港协作组.植入式静脉输液港(浙江)临床应用多学科专家共识[J]. 实用肿瘤杂志,2018, 33(1):17-24.
|
[16] |
傅麒宁,吴洲鹏,孙文彦,等.《输液导管相关静脉血栓形成中国专家共识》临床实践推荐[J]. 中国普外基础与临床杂志,2020, 27(4):412-418.
|